Position in AMGN
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$9,498,769
+$1,439,645 QoQ
Shares Held
26,231
+14.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#565
of 3,140 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tema ETFs LLC holds $109,379,794 across 9 Drug Manufacturers - General names. AMGN ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
25,006 | $29,992,949 | |
| 2 | JNJ |
Johnson & Johnson
|
73,885 | $18,764,573 | |
| 3 | MRK |
Merck & Co., Inc.
|
122,900 | $15,792,650 | |
| 4 | ABBV |
AbbVie Inc.
|
61,759 | $15,541,034 | |
| 5 | AMGN |
Amgen Inc
This page
|
26,231 | $9,498,769 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
164,530 | $9,480,218 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
57,158 | $7,221,341 | |
| 8 | PFE |
Pfizer Inc
|
103,378 | $2,489,342 |
All Filings in AMGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,498,769 | 26,231 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $8,059,124 | 22,905 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $6,589,404 | 20,132 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $5,069,440 | 17,964 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $3,623,308 | 12,977 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,032,627 | 9,734 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,913,694 | 11,179 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||